Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective, Randomized Evaluation of New Onset Postoperative Atrial Fibrillation in Subjects Receiving the CorMatrix® ECM® for Pericardial Closure

NCT01247974 is registered in ClinicalTrials.gov with Elutia Inc. as lead sponsor.

NCT NCT01247974
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01247974 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective, Randomized Evaluation of New Onset Postoperative Atrial Fibrillation in Subjects Receiving the CorMatrix® ECM® for Pericardial Closure
Lead sponsor
Elutia Inc.
Phase
Not applicable
Overall status
Completed
Start date
December 31, 2010
Completion date
December 31, 2012
Enrollment
439 (actual)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation new onset